| scholarly article | Q13442814 |
| P356 | DOI | 10.1034/J.1600-079X.2003.00057.X |
| P698 | PubMed publication ID | 12887649 |
| P50 | author | Dun-Xian Tan | Q88219254 |
| Russel J Reiter | Q89645924 | ||
| P2093 | author name string | Sergio Rosales-Corral | |
| Genaro G Ortiz | |||
| J Pablo Acosta-Martínez | |||
| Miguel Valdivia-Velázquez | |||
| Gabriela Martínez-Barboza | |||
| P2860 | cites work | Inflammation and Alzheimer's disease | Q28138617 |
| Significance of melatonin in antioxidative defense system: reactions and products | Q33909992 | ||
| Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease | Q34076863 | ||
| Melatonin: a peroxyl radical scavenger more effective than vitamin E. | Q34323905 | ||
| Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury | Q34348724 | ||
| Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence | Q34566877 | ||
| Melatonin-immune system relationships | Q34567195 | ||
| Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. | Q34737994 | ||
| The chemistry of melatonin's interaction with reactive species | Q35027014 | ||
| Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. | Q35969894 | ||
| Alzheimer's disease: a central role for amyloid | Q40701623 | ||
| High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells. | Q41045694 | ||
| Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications | Q41377025 | ||
| Hydrogen peroxide mediates amyloid beta protein toxicity | Q41460857 | ||
| Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. | Q41712816 | ||
| The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors | Q44034608 | ||
| Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin | Q48703440 | ||
| Alzheimer's disease. Amyloid ox-tox transducers. | Q53212905 | ||
| Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal | Q68592280 | ||
| Melatonin as a therapeutic agent in experimental endotoxic shock | Q71551522 | ||
| Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen | Q71904117 | ||
| Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation | Q73308716 | ||
| Genotoxicity of paraquat: micronuclei induced in bone marrow and peripheral blood are inhibited by melatonin | Q73387879 | ||
| Subacute NO generation induced by Alzheimer's beta-amyloid in the living brain: reversal by inhibition of the inducible NO synthase | Q74121518 | ||
| Reaction of peroxynitrite with melatonin: A mechanistic study | Q77880265 | ||
| P433 | issue | 2 | |
| P921 | main subject | vitamin C | Q199678 |
| melatonin | Q180912 | ||
| P304 | page(s) | 80-84 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | Journal of Pineal Research | Q15056565 |
| P1476 | title | Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-beta peptide in rat brain: a comparative, in vivo study versus vitamin C and E. | |
| P478 | volume | 35 |
| Q35986729 | Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin |
| Q35993891 | Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-β: A Protective Role of Melatonin |
| Q93212726 | Antidepressant agomelatine attenuates behavioral deficits and concomitant pathology observed in streptozotocin-induced model of Alzheimer's disease in male rats |
| Q97067410 | Association Between Vitamins and Amyotrophic Lateral Sclerosis: A Center-Based Survey in Mainland China |
| Q80198383 | Comparative effects of melatonin and vitamin E in restoring aortic relaxation in pancreatectomized rats |
| Q35115052 | Diaphragmatic breathing reduces exercise-induced oxidative stress |
| Q37620654 | High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice |
| Q33652344 | Influence of melatonin on cerebrovascular proinflammatory mediators expression and oxidative stress following subarachnoid hemorrhage in rabbits. |
| Q33830681 | L-ascorbate attenuates the endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation and NF-κB translocation in cortical neurons/glia Cocultures |
| Q39178920 | Mechanisms of Melatonin in Alleviating Alzheimer's Disease |
| Q36335048 | Melatonin Therapy in Patients with Alzheimer's Disease |
| Q48237622 | Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus |
| Q36282826 | Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis |
| Q48113837 | Melatonin and the human hippocampus, a time dependent interplay |
| Q38022179 | Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes |
| Q44739251 | Melatonin attenuates cognitive dysfunction and reduces neural oxidative stress induced by phosphamidon |
| Q38834700 | Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases. |
| Q37091982 | Melatonin in Alzheimer's disease |
| Q92404286 | Melatonin: Clinical Perspectives in Neurodegeneration |
| Q34014678 | Melatonin: an established antioxidant worthy of use in clinical trials. |
| Q28075345 | Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms |
| Q38250489 | Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin |
| Q64880531 | Natural Compounds for Alzheimer's Disease Therapy: A Systematic Review of Preclinical and Clinical Studies. |
| Q22305781 | Neurotoxins: free radical mechanisms and melatonin protection |
| Q37741560 | Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease |
| Q91804786 | Pineal gland dysfunction in Alzheimer's disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis |
| Q46294346 | Preventive and therapeutic potential of ascorbic acid in neurodegenerative diseases |
| Q52660268 | Profiling donepezil template into multipotent hybrids with antioxidant properties. |
| Q36433222 | Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice |
| Q42705994 | Protective effect of melatonin on propoxur-induced impairment of memory and oxidative stress in rats |
| Q36346522 | Role of melatonin in Alzheimer-like neurodegeneration |
| Q26799870 | Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease |
| Q33828357 | Sodium-dependent vitamin C transporter 2 (SVCT2) expression and activity in brain capillary endothelial cells after transient ischemia in mice |
| Q22241784 | The Possible Role of Antioxidant Vitamin C in Alzheimer's Disease Treatment and Prevention |
| Q58800989 | The Timing of Melatonin Administration Is Crucial for Its Antidepressant-Like Effect in Mice |
| Q37113535 | Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. |
| Q38666196 | Vitamin C, Aging and Alzheimer's Disease. |
Search more.